Showing results (31-40 of 68) with videos related to
Sort By:
Pageof 7
PDA Journal of Pharmaceutical Science and Technology|January 25, 2005
Pharmaceutical development of an intravenous dosage form of diacetylmorphine hydrochlorideMarjolein G Klous, Bastiaan Nuijen, Wim van den Brink, et al.Addiction (Abingdon, England)|December 16, 2004
Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trialsPeter Blanken, Vincent M Hendriks, Maarten W J Koeter, et al.Drug and Alcohol Dependence|July 26, 2011
Craving and illicit heroin use among patients in heroin-assisted treatmentPeter Blanken, Vincent M Hendriks, Maarten W J Koeter, et al.Clinical Pharmacokinetics|April 6, 2006
Population pharmacokinetics of heroin and its major metabolitesElisabeth J Rook, Alwin D R Huitema, Wim van den Brink, et al.Current Clinical Pharmacology|August 1, 2008
Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literatureElisabeth J Rook, Alwin D R Huitema, Wim van den Brink, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 6, 2003
Behavioural changes after different stress paradigms: prepulse inhibition increased after physical, but not emotional stressFemke T A Pijlman, Arnoud H J Herremans, Jan van de Kieft, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 6, 2003
Neonatal lesions in the amygdala or ventral hippocampus disrupt prepulse inhibition of the acoustic startle response; implications for an animal model of neurodevelopmental disorders like schizophreniaElisabeth W P M Daenen, Gerrit Wolterink, Jan A Van Der Heyden, et al.Pharmacogenomics|April 16, 2019
VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependenceMatthew Randesi, Wim van den Brink, Orna Levran, et al.Drug and Alcohol Dependence|June 30, 2006
Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatmentBart P van der Zanden, Marcel G W Dijkgraaf, Peter Blanken, et al.Pharmacogenomics|August 8, 2020
Further evidence for the association of GAL, GALR1 and NPY1R variants with opioid dependenceMatthew Randesi, Orna Levran, Wim van den Brink, et al.Pageof 7